Skip to main content
Clinical and Experimental Immunology logoLink to Clinical and Experimental Immunology
. 1972 Oct;12(2):195–203.

Evaluation of cell mediated immune responses in untreated cases of leprosy

G P Talwar, A D Krishnan, V L Mehra, E A Blum, J M H Pearson
PMCID: PMC1553575  PMID: 4567646

Abstract

Twenty-three leprosy patients have been studied in an endemic area before institution of chemotherapy. These were comprised of ten lepromatous leprosy, four borderline lepromatous and nine tuberculoid leprosy cases on basis of clinical features, bacteriological and marphological indices. Histopathology of skin biopsies classified two as truly polar lepromatous leprosy (LL) and three as polar tuberculoid (TT), while the remaining eighteen were at various stages of evolution towards lepromatous or tuberculoid end of the spectrum. All lepromatous and borderline leprosy patients showed negative delayed hypersensitivity reaction with lepromin, but six out of fourteen patients in this category gave positive reaction with PPD. Blast transformation with PHA of peripheral leucocytes from all cases of lepromatous leprosy cultured in standard AB serum was depressed in comparison with cells from normal controls. 3H-thymidine incorporation in DNA of leucocytes in presence of leprolin was lower in cells of lepromatous leprosy group as compared to those from tuberculoid and borderline cases. There was lack of production of macrophage aggregation factor in all except one case of lepromatous leprosy while the test for this factor was positive for most of the tuberculoid leprosy patients. The homing characteristics of lymphocytes tagged with 51Chromium into liver and spleen of test mice were altered from the normal pattern in a large number of leprosy cases.

Full text

PDF
195

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Dierks R. E., Shepard C. C. Effect of phytohemagglutinin and various mycobacterial antigens on lymphocyte cultures from leprosy patients. Proc Soc Exp Biol Med. 1968 Feb;127(2):391–395. doi: 10.3181/00379727-127-32698. [DOI] [PubMed] [Google Scholar]
  2. Gaafar S. M., Turk J. L. Granuloma formation in lymph-nodes. J Pathol. 1970 Jan;100(1):9–20. doi: 10.1002/path.1711000103. [DOI] [PubMed] [Google Scholar]
  3. HANKS J. H., CHATTERJEE B. R., LECHAT M. F. A GUIDE TO THE COUNTING OF MYCOBACTERIA IN CLINICAL AND EXPERIMENTAL MATERIALS. Int J Lepr. 1964 Apr-Jun;32:156–167. [PubMed] [Google Scholar]
  4. Lolekha S., Dray S., Gotoff S. P. Macrophage aggregation in vitro: a correlate of delayed hypersensitivity. J Immunol. 1970 Feb;104(2):296–304. [PubMed] [Google Scholar]
  5. Martin W. J., Miller J. F. Assay for the immunosuppressive capacity of antilymphocyte serum based on its action on thymus-derived cells. Int Arch Allergy Appl Immunol. 1969;35(2):163–178. doi: 10.1159/000230169. [DOI] [PubMed] [Google Scholar]
  6. Nelson D. S., Nelson M., Thurston J. M., Waters M. F., Pearson J. M. Phytohaemagglutinin-induced lymphocyte transformation in leprosy. Clin Exp Immunol. 1971 Jul;9(1):33–43. [PMC free article] [PubMed] [Google Scholar]
  7. Ridley D. S., Jopling W. H. Classification of leprosy according to immunity. A five-group system. Int J Lepr Other Mycobact Dis. 1966 Jul-Sep;34(3):255–273. [PubMed] [Google Scholar]
  8. Turk J. L., Waters M. F. Cell-mediated immunity in patients with leprosy. Lancet. 1969 Aug 2;2(7614):243–246. doi: 10.1016/s0140-6736(69)90009-9. [DOI] [PubMed] [Google Scholar]
  9. Turk J. L., Waters M. F. Immunological basis for depression of cellular immunity and the delayed allergic response in patients with lepromatous leprosy. Lancet. 1968 Aug 24;2(7565):436–438. doi: 10.1016/s0140-6736(68)90472-8. [DOI] [PubMed] [Google Scholar]
  10. Turk J. L., Willoughby D. A. Central and peripheral effects of anti-lymphocyte sera. Lancet. 1967 Feb 4;1(7484):249–251. doi: 10.1016/s0140-6736(67)91307-4. [DOI] [PubMed] [Google Scholar]
  11. Waldorf D. S., Sheagren J. N., Trautman J. R., Block J. B. Impaired delayed hypersensitivity in patients with lepromatous leprosy. Lancet. 1966 Oct 8;2(7467):773–776. doi: 10.1016/s0140-6736(66)90366-7. [DOI] [PubMed] [Google Scholar]

Articles from Clinical and Experimental Immunology are provided here courtesy of British Society for Immunology

RESOURCES